scholarly journals Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatin.

1988 ◽  
Vol 32 (5) ◽  
pp. 773-774
Author(s):  
M S Verdon ◽  
F N Judson ◽  
J M Ehret ◽  
C J Root ◽  
E W Hook ◽  
...  
1984 ◽  
Vol 11 ◽  
pp. 404-406
Author(s):  
KANCHANA PANIKABUTRA ◽  
CHARAS ARIYARIT ◽  
ANUPONG CHITWARAKORN ◽  
AMPORN SOONTHARARAK ◽  
CHOOSAK SAENSANOH

1985 ◽  
Vol 12 (4) ◽  
pp. 184-187 ◽  
Author(s):  
RICHARD C. REICHMAN ◽  
FREDERICK S. NOLTE ◽  
STEVEN M. WOLINSKY ◽  
CAROL A. GREISBERGER ◽  
MARY ANNE TRUPEI ◽  
...  

1997 ◽  
Vol 41 (8) ◽  
pp. 1843-1845 ◽  
Author(s):  
E W Hook ◽  
W M McCormack ◽  
D Martin ◽  
R B Jones ◽  
K Bean ◽  
...  

In a randomized open study, 351 male patients with uncomplicated gonorrhea were given single oral doses of grepafloxacin (400 mg) or cefixime (400 mg). In the 299 microbiologically evaluable patients, urethral infections were cured in 99% (147 of 149) of those receiving grepafloxacin and 97% (145 of 150) of those given cefixime. Eradication rates for both regimens were 100% in the 16% (47 of 299) of participants who were infected with penicillin-resistant Neisseria gonorrhoeae and 97% in the 21% (62 of 299) of participants infected with tetracycline-resistant strains. Grepafloxacin is a well-tolerated alternative to cefixime for treatment of uncomplicated gonorrhea in males.


1994 ◽  
Vol 21 (6) ◽  
pp. 345-352 ◽  
Author(s):  
ROGER M. ECHOLS ◽  
ALLEN HEYD ◽  
BRIAN J. OʼKEEFFE ◽  
PETER SCHACHT

1985 ◽  
Vol 12 (2) ◽  
pp. 90-92 ◽  
Author(s):  
H. HUNTER HANDSFIELD ◽  
VICTORY L. MURPHY

1996 ◽  
Vol 40 (12) ◽  
pp. 2775-2780 ◽  
Author(s):  
E M Thorpe ◽  
J R Schwebke ◽  
E W Hook ◽  
A Rompalo ◽  
W M McCormack ◽  
...  

A randomized, multicenter, investigator-blind trial was conducted to compare the efficacies of cefuroxime axetil and ciprofloxacin for treatment of patients with uncomplicated gonorrhea caused by penicillinase-producing Neisseria gonorrhoeae (PPNG). A total of 832 patients (434 females and 398 males) received a single oral dose of cefuroxime axetil (1,000 mg [417 patients]) or ciprofloxacin (500 mg [415 patients]). N. gonorrhoeae was eradicated from the cervix in 114 of 118 (97%) and 118 of 119 (99%) bacteriologically evaluable females treated with cefuroxime axetil and ciprofloxacin, respectively (P = 0.213; difference, -2%; 95% confidence interval, -6 to 1%), and from the urethra in 154 of 166 (93%) and 171 of 171 (100%) bacteriologically evaluable male patients treated with cefuroxime axetil and ciprofloxacin, respectively (P < 0.001; difference, -7%; 95% confidence interval, -11 to -3%). Both treatments were effective in eradicating N. gonorrhoeae in females with rectal infections (cefuroxime axetil, 29 of 30 [97%]; ciprofloxacin, 25 of 25 [100%]; P = 1.00). In small numbers of patients, cefuroxime axetil was less effective than ciprofloxacin in treating males with pharyngeal infections (eradication in 4 of 10 and in 8 of 8 patients, respectively; P = 0.013). PPNG was eradicated from the cervix in 22 of 23 (96%) and 32 of 32 (100%) bacteriologically evaluable female patients treated with cefuroxime axetil and ciprofloxacin, respectively (P = 0.418; difference, -4%; 95% confidence interval, -13 to 4%), and from the urethra in 35 of 36 (97%) and 34 of 34 (100%) bacteriologically evaluable male patients treated with cefuroxime axetil and ciprofloxacin, respectively (P = 1.00; difference, -3%; 95% confidence interval, -8 to 3%). The incidences of drug-related adverse events were similar for the two study drugs. In summary, treatment with a single oral dose of cefuroxime axetil is as effective as treatment with a single oral dose of ciprofloxacin in eradicating PPNG from males and females with uncomplicated gonorrhea (urethral and endocervical), and both regimens are well-tolerated. However, in the present study, cefuroxime axetil was less effective than ciprofloxacin in treating urethral gonococcal infections in male patients, although both study drugs were highly effective in treating cervical gonococcal infections in female patients.


1992 ◽  
Vol 19 (6) ◽  
pp. 341-345 ◽  
Author(s):  
LARRY M. BADDOUR ◽  
LINDA BUSBY ◽  
ELISE SHAPIRO ◽  
KAYE B. COX ◽  
SUMNER GLASSCO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document